Final stage clinical trial data on RTS,S, also known as Mosquirix, showed it halved the risk of African children getting malaria, making it likely to become the world’s first successful vaccine against the deadly disease. (via Malaria scientist celebrates success after 24 years | Reuters)
Oct20
